Treatment for Healthy Subjects (HS)

Phase-Based Progress Estimates
Mayo Clinic Rochester, Rochester, MN
Healthy Subjects (HS)
18 - 65
All Sexes
What conditions do you have?

Study Summary

The purpose of this study is to investigate how gut hormones and brain areas respond differently to gastric distention, tasteless calories, or palatable food and how this alters appetite.

Treatment Effectiveness

Effectiveness Progress

1 of 3

Study Objectives

1 Primary · 9 Secondary · Reporting Duration: 1 month

1 month
Primary Endpoint
Secondary Endpoint 1
Secondary Endpoint 2
Secondary Endpoint 3
Secondary Endpoint 4
Secondary Endpoint 6
Secondary Endpoint 7
Secondary Endpoint 8
Secondary Endpoint 9
Secondary Endpoints 5

Trial Safety

Safety Progress

1 of 3

Trial Design

0 Treatment Group

15 Total Participants · 0 Treatment Group

Primary Treatment: Treatment · No Placebo Group · N/A

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: 1 month
Closest Location: Mayo Clinic Rochester · Rochester, MN
Photo of Mayo Clinic Rochester 1Photo of Mayo Clinic Rochester 2Photo of Mayo Clinic Rochester 3
2005First Recorded Clinical Trial
6 TrialsResearching Healthy Subjects (HS)
157 CompletedClinical Trials

Who is running the clinical trial?

Mayo ClinicLead Sponsor
2,860 Previous Clinical Trials
3,686,146 Total Patients Enrolled
81 Trials studying Healthy Subjects (HS)
21,081 Patients Enrolled for Healthy Subjects (HS)
Andres Acosta, MD, PhDPrincipal InvestigatorMayo Clinic
2 Previous Clinical Trials
116 Total Patients Enrolled
1 Trials studying Healthy Subjects (HS)
36 Patients Enrolled for Healthy Subjects (HS)

Eligibility Criteria

Age 18 - 65 · All Participants · 5 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:
You have a body mass index (BMI) of 18-25 kg/m^2.
You are able to provide written informed consent prior to any study procedures and be willing and able to follow study procedures.
For females: study days will be scheduled during the follicular phase of their menstrual cycle (i.e., the first 13 days (about 2 weeks) of the cycle).

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 9th, 2021

Last Reviewed: August 12th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.